Prestige Consumer Healthcare closes $1.045B Breathe Right acquisition, financed with new term loan

Filed June 16, 2026 · Period ending June 12, 2026 · ~1 min read

Key Changes

• high

  Completed acquisition of Breathe Right nasal strip brand and related products for $1.045 billion cash ($900M net of $150M anticipated tax benefits), making it the company's largest brand and expanding into a new category.

  Item 2.01 verify on EDGAR →
• high

  Financed acquisition with new $1.045B term loan at SOFR+2.00% maturing 2031, with quarterly 0.25% principal amortization and mandatory prepayments from asset sales and excess cash flow if leverage exceeds 2.75x starting fiscal 2028.

  Item 1.01 verify on EDGAR →
• medium

  Amended asset-based revolving credit facility, increasing commitments to $225M and extending maturity to 2031, providing additional liquidity for operations and potential future acquisitions.

  Item 1.01 verify on EDGAR →